Biologic monitoring of the efficacy of immunosuppression in liver transplant patients.
Farges
O
O
Hepato-Biliary Surgery and Liver Transplant Center, Hôpital Paul Brousse, University Paris Sud, Villejuif, France.
Buffello
D
D
Swercz
B
B
deGroote
D
D
Bismuth
H
H
D001663:Bilirubin / Q000097:blood; D002478:Cells, Cultured; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D016207:Cytokines / Q000096:biosynthesis*; D016903:Drug Monitoring; D006084:Graft Rejection / Q000175:diagnosis; D006801:Humans; D007165:Immunosuppression Therapy; D007371:Interferon-gamma / Q000096:biosynthesis; D007376:Interleukin-2 / Q000096:biosynthesis; D015847:Interleukin-4 / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000494:pharmacology; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D010835:Phytohemagglutinins / Q000494:pharmacology
D016207:Cytokines; D007376:Interleukin-2; D008070:Lipopolysaccharides; D010835:Phytohemagglutinins; D015847:Interleukin-4; D007371:Interferon-gamma; D016572:Cyclosporine; D001663:Bilirubin